Journal of Asthma and Allergy
Volume 12, 2019 - Issue
Open access
185
Views
13
CrossRef citations to date
0
Altmetric
Original Research
Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study
Jean-Pierre Llanos1 Respiratory, US Medical Affairs, GSK, Research Triangle Park, NC, USA, [email protected]
, Christopher F Bell1 Respiratory, US Medical Affairs, GSK, Research Triangle Park, NC, USA, [email protected]
, Elizabeth Packnett2 Truven Health Analytics, An IBM Watson Health Company, Ann Arbor, MI, USA
, Ellen Thiel2 Truven Health Analytics, An IBM Watson Health Company, Ann Arbor, MI, USA
, Debra E Irwin2 Truven Health Analytics, An IBM Watson Health Company, Ann Arbor, MI, USA
, Beth Hahn1 Respiratory, US Medical Affairs, GSK, Research Triangle Park, NC, USA, [email protected]Correspondence[email protected]
& Hector Ortega3 Respiratory, US Medical Affairs, GSK, La Jolla, CA, USA
show all
Pages 43-58
|
Published online: 25 Jan 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.